Export

Deferoxamine
Essential medicine status
Section:
10. Medicines affecting the blood 10.3. Other medicines for haemoglobinopathies
ATC codes: V03AC01
EMLc
Indication
Other specified sickle cell disorders or other haemoglobinopathies ICD11 code: 3A51.Y
INN
Deferoxamine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)
EML status history
First added in 2011 (TRS 965)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
deferasirox (ATC codes: V03AC03)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Deferoxamine
DrugBank
Deferoxamine
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended oral deferasirox be specified as a therapeutic alternative under the square box listing for deferoxamine on the EML and EMLc for this indication.